Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Clinical Psychiatry|July 9, 2014
The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.
BMC Medicine|August 16, 2012
Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trialMichael Berk, Olivia M Dean, Sue M Cotton, et al.
Journal of Affective Disorders|July 2, 2011
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trialMichael Berk, Olivia Dean, Sue M Cotton, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 3, 2025
[Psychosocial aspects of Long COVID - A psychotherapeutic treatment manual from the PsyLoCo project]Tamara Frank, Paul Bruckmann, Marius Binneböse, et al.
Vaccines|May 28, 2022
COVID-19 Vaccines: Fear of Side Effects among German Health Care WorkersChristopher Holzmann-Littig, Tamara Frank, Christoph Schmaderer, et al.
Frontiers in Psychiatry|March 21, 2024
Addressing psychosocial needs in patients with Long-COVID (PsyLoCo-Study): study protocol of a pilot-study of a specialized modular interventionChristine Allwang, Tamara Frank, Paul Bruckmann, et al.
BMJ Open|September 22, 2020
Depression screening using patient-targeted feedback in general practices: study protocol of the German multicentre GET.FEEDBACK.GP randomised controlled trialSebastian Kohlmann, Marco Lehmann, Marion Eisele, et al.
Psychotherapy and Psychosomatics|August 21, 2019
Cognitive Behaviour Therapy Complemented with Emotion Regulation Training for Patients with Persistent Physical Symptoms: A Randomised Clinical TrialMaria Kleinstäuber, Christine Allwang, Josef Bailer, et al.
The Lancet. Psychiatry|March 3, 2024
Clinical effectiveness of patient-targeted feedback following depression screening in general practice (GET.FEEDBACK.GP): an investigator-initiated, prospective, multicentre, three-arm, observer-blinded, randomised controlled trial in GermanyBernd Löwe, Martin Scherer, Lea-Elena Braunschneider, et al.
Pageof 2